Literature DB >> 15267244

Probing the activity differences of simple and complex brominated aryl compounds against 15-soybean, 15-human, and 12-human lipoxygenase.

Erika N Segraves1, Rachana R Shah, Nathaniel L Segraves, Tyler A Johnson, Stephanie Whitman, Jennifer K Sui, Victor A Kenyon, Robert H Cichewicz, Phillip Crews, Theodore R Holman.   

Abstract

Lipoxygenases (LO) have been implicated in asthma, immune disorders, and various cancers. As a consequence of these broad biological implications, there is great interest in understanding the effects of naturally occurring and environmental contaminants against its activity. On the basis of our earlier studies indicating that polybrominated diphenol ethers are potent inhibitors to mammalian 15-LO, we expanded our structure-activity study to include marine-derived brominated phenol ethers (including a newly discovered tribrominated diphenyl ether), dioxins, and bastadins, as well as the synthetic brominated fire retardants, brominated bisphenol A (BBPA), and polybrominated diphenyl ethers (PBDEs). We report herein the effects of 21 simple and complex organobromine compounds against human platelet 12-LO, human reticulocyte 15-LO, and soybean 15-LO-1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15267244     DOI: 10.1021/jm049872s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase.

Authors:  Diane K Luci; J Brian Jameson; Adam Yasgar; Giovanni Diaz; Netra Joshi; Auric Kantz; Kate Markham; Steve Perry; Norine Kuhn; Jennifer Yeung; Edward H Kerns; Lena Schultz; Michael Holinstat; Jerry L Nadler; David A Taylor-Fishwick; Ajit Jadhav; Anton Simeonov; Theodore R Holman; David J Maloney
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

2.  Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.

Authors:  Victor Kenyon; Ganesha Rai; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Steven Perry; Netra Joshi; James M Bougie; William Leister; David A Taylor-Fishwick; Jerry L Nadler; Michael Holinstat; Anton Simeonov; David J Maloney; Theodore R Holman
Journal:  J Med Chem       Date:  2011-07-08       Impact factor: 7.446

3.  Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.

Authors:  Ganesha Rai; Victor Kenyon; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Eric Hoobler; William Leister; Anton Simeonov; Theodore R Holman; David J Maloney
Journal:  J Med Chem       Date:  2010-10-28       Impact factor: 7.446

Review 4.  Lipids and immunoinflammatory pathways of beta cell destruction.

Authors:  Yumi Imai; Anca D Dobrian; Margaret A Morris; David A Taylor-Fishwick; Jerry L Nadler
Journal:  Diabetologia       Date:  2016-02-11       Impact factor: 10.122

5.  Complexity of naturally produced polybrominated diphenyl ethers revealed via mass spectrometry.

Authors:  Vinayak Agarwal; Jie Li; Imran Rahman; Miles Borgen; Lihini I Aluwihare; Jason S Biggs; Valerie J Paul; Bradley S Moore
Journal:  Environ Sci Technol       Date:  2015-01-21       Impact factor: 9.028

Review 6.  Minireview: 12-Lipoxygenase and Islet β-Cell Dysfunction in Diabetes.

Authors:  Sarah A Tersey; Esther Bolanis; Theodore R Holman; David J Maloney; Jerry L Nadler; Raghavendra G Mirmira
Journal:  Mol Endocrinol       Date:  2015-03-24

7.  NMR strategy for unraveling structures of bioactive sponge-derived oxy-polyhalogenated diphenyl ethers.

Authors:  Laurent Calcul; Raymond Chow; Allen G Oliver; Karen Tenney; Kimberly N White; Alexander W Wood; Catherine Fiorilla; Phillip Crews
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

Review 8.  Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications.

Authors:  A D Dobrian; M A Morris; D A Taylor-Fishwick; T R Holman; Y Imai; R G Mirmira; J L Nadler
Journal:  Pharmacol Ther       Date:  2018-10-19       Impact factor: 12.310

9.  Pseudoperoxidase investigations of hydroperoxides and inhibitors with human lipoxygenases.

Authors:  Eric K Hoobler; Charles Holz; Theodore R Holman
Journal:  Bioorg Med Chem       Date:  2013-04-18       Impact factor: 3.641

10.  Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.

Authors:  Yesseny Vasquez-Martinez; Rachana V Ohri; Victor Kenyon; Theodore R Holman; Silvia Sepúlveda-Boza
Journal:  Bioorg Med Chem       Date:  2007-08-22       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.